
On June 7, the F.D.A approved the use of the controversial Alzheimer’s treatment Aduhelm. This led to a backlash from many Alzheimer’s experts, who say that evidence for the drug’s effectiveness is limited.
On June 7, the F.D.A approved the use of the controversial Alzheimer’s treatment Aduhelm. This led to a backlash from many Alzheimer’s experts, who say that evidence for the drug’s effectiveness is limited.
Republicans could try again to repeal Obamacare if they win enough seats in U.S. elections next month, Senate Republican Leader Mitch McConnell said on Wednesday, calling a failed 2017 push to repeal the healthcare law a "disappointment."
In what turns out to be yet another blatant Trump lie, when he promised to take decisive action to reduce the rising cost of medicine, and stop pharmaceutical corporations from “getting away with murder” with exorbitant and ever-rising drug prices, he didn't get approval from the big pharmaceutical companies.